Understanding Cholesterol Guidelines and Implementing Non-statins in High-Risk Populations: Paired Conversations and Case Vignettes
Released On
December 29, 2023
Expires On
December 20, 2024
Media Type
Internet
Completion Time
90 Minutes
Specialty
Cardiology, Pharmacy, Primary Care
Topic(s)
Acute Heart Failure, Acute Myocardial Infarction, Cardiovascular Disease, Heart Disease
Sponsored by the Annenberg Center for Health Sciences.
This activity is supported by an independent educational grant from Novartis Pharmaceuticals Corporation.
Credit Available
- Physicians — maximum of 1.5 AMA PRA Category 1 Credits™
- Pharmacists — 1.5 CPE Hours
- Nurses — 1.5 American Nurses Credentialing Center (ANCC) Contact Hour, including 1.5 pharmacology hours
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity was developed for cardiologists, lipidologists, internal medicine specialists, primary care physicians, nurse practitioners, physician associates/assistants, pharmacists and other clinicians who have a role in the diagnosis, treatment, and monitoring of patients with hyperlipidemia.
Program Overview
An interprofessional faculty of primary care and specialty clinicians discuss real-world issues in managing patients with complex and challenging dyslipidemia, including elevated lipoprotein a (Lp(a)). Several paired conversations serve as the foundation for discussions related to recent cholesterol guidelines, patient risk stratification, and recommended goals for patients at risk of atherosclerotic cardiovascular disease. Two case vignettes provide the basis for robust discussion among the faculty, which centers around clinical decision-making and the roles, benefits, and limitations of approved and investigational pharmacologic treatment options. The 1.5-hour program format fosters critical thinking and application of key concepts to patient cases, enabling participants to advance their clinical practice.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Understanding of Lp(a) recommendations and management according to recent cholesterol guidelines
- Implement nonstatin therapy among those not achieving lipid treatment targets with or not tolerating statin therapy
- Utilize validated risk assessment tools to classify individual patients
- Recognize lipid targets and thresholds for initiating nonstatin therapy
- Implement strategies to limit common barriers for initiating nonstatin therapies
- Utilize practice cases for understanding guideline recommendations for initiating new therapies
Faculty
John E. Anderson, MD
Internal Medicine and Diabetes
The Frist Clinic
Nashville, Tennessee
James M. Backes, PharmD
Professor
Associate Dean for Clinical and Medical Center Affairs
Assistant Director Atherosclerosis and LDL-Apheresis Center
School of Pharmacy
Kansas City, Kansas
Deepak L. Bhatt, MD, MPH
Director, Mount Sinai Heat
Dr. Valentin Fuster Professor of Cardiovascular Medicine
Icahn School of Medicine
Mount Sinai Health System
New York, New York
Seth S. Martin, MD
Professor
Director of the Advanced Lipid Disorders Program and Digital Health Lab
Ciccarone Center for the Prevention of Cardiovascular Disease
Associate Professor of Medicine
Johns Hopkins
Baltimore, Maryland
Colleen Walsh-Irwin, DNP
Associate Director
Evidence-Based Practice at Department of Veterans Affairs
E. Northport, New York
Accreditation Statement
In support of improving patient care, Annenberg Center for Health Sciences at Eisenhower (Annenberg Center) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit
The Annenberg Center designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Credit
The Annenberg Center designates this knowledge-based activity for a maximum of 1.5 hours.Credit will be provided to NABP CPE Monitor within 45 days after the activity completion.
Nurse Credit
The Annenberg Center designates this education for a maximum of 1.5 American Nurses Credentialing Center (ANCC) contact hours, including 1.5 pharmacology hours.
Provider is approved by the California Board of Registered Nursing, Provider #13664, for 1.5 contact hour. To receive credit for education contact hours outside of the state of California, please check with your state board of registered nursing for reciprocity.
Disclosures of Conflicts of Interest
- John E. Anderson, MD
- Advisory Board: Abbott Diabetes
- Consultant: Bayer, Biolink, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Sanofi
- Speakers Bureau: Bayer, Eli Lilly, Novo Nordisk, Sanofi
- Deepak L. Bhatt, MD, MPH
- Advisory Board: Angiowave, Bayer, Boehringer Ingelheim, CellProthera, Cereno Scientific, Janssen, McKinsey, Merck, MyoKardia, NirvaMed, Novo Nordisk, PhaseBio, PLx Pharma, Stasys
- Consultant: GlaxoSmithKline, Hims, SFJ, Youngene
- Data Monitoring Committees: Acesion Pharma, Boston Scientific, Contego Medical, Novartis
- Honoraria: CSL Behring (AHA lecture), Cowen and Company, Piper Sandler
- Research Funding: Abbott, Acesion Pharma, Afimmune, Aker Biomarine, Alnylam, Amarin, Amgen, AstraZeneca, Bayer, Beren, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb, Cardax, CellProthera, Cereno Scientific, Chiesi, CinCor, Cleerly, CSL Behring, Eisai, Ethicon, Faraday Pharmaceuticals, Ferring Pharmaceuticals, Forest Laboratories, Fractyl, Garmin, HLS Therapeutics, Idorsia, Ironwood, Ischemix, Janssen, Javelin, Lexicon, Lilly, Medtronic, Merck, Moderna, MyoKardia, NirvaMed, Novartis, Novo Nordisk, Otsuka, Owkin, Pfizer, PhaseBio, PLx Pharma, Recardio, Regeneron, Reid Hoffman Foundation, Roche, Sanofi, Stasys, Synaptic, The Medicines Company, Youngene, 89Bio
- Site Co-Investigator: Abbott, Biotronik, Boston Scientific, CSI, Endotronix, St. Jude Medical (now Abbott), Philips, SpectraWAVE, Svelte, Vascular Solutions; Unfunded Research: FlowCo.
- Seth S. Martin, MD
- Advisory Board: Amgen, AstraZeneca, BMS, Merck, NewAmsterdam
- Consultant: Premier
The following have no significant relationship to disclose:
James Backes, PharmD (Medical Writer)
Jada Dillner, PA (Peer Reviewer)
Heather M. Jimenez, FNP-C (Nurse Reviewer)
Annenberg Center for Health Sciences:
All staff at the Annenberg Center have no relevant financial relationships to disclose.
All the relevant financial relationships listed for these individuals have been mitigated.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be emailed to the participant.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
The faculty for this activity has disclosed that there will be discussion about the use of products for non-FDA approved indications.
Disclaimer
The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient's unique clinical situation. The Annenberg Center for Health Sciences at Eisenhower disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.
Contact Information
For CME questions please contact: [email protected].